153 related articles for article (PubMed ID: 30483478)
1. Monitoring the Process of Endostar-Induced Tumor Vascular Normalization by Non-contrast Intravoxel Incoherent Motion Diffusion-Weighted MRI.
Pan JH; Zhu S; Huang J; Liang J; Zhang D; Zhao X; Ding H; Qin L; Shi C; Luo L; Pan Y
Front Oncol; 2018; 8():524. PubMed ID: 30483478
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of tumor vascular normalization in colorectal cancer mouse mode induced by recombinant human endostatin by intravoxel incoherent motion diffusion-weighted magnetic resonance imaging].
Zhu SB; Huang JL; Pan JH; Ding H; Zhao XX; Zhang D; Shi CZ; Pan YL
Zhonghua Zhong Liu Za Zhi; 2019 Jun; 41(6):421-428. PubMed ID: 31216827
[No Abstract] [Full Text] [Related]
3. Monitoring Bevacizumab-Induced Tumor Vascular Normalization by Intravoxel Incoherent Motion Diffusion-Weighted MRI.
Li B; Xu D; Zhou J; Wang SC; Cai YX; Li H; Xu HB
J Magn Reson Imaging; 2022 Aug; 56(2):427-439. PubMed ID: 34873766
[TBL] [Abstract][Full Text] [Related]
4. Evaluating the efficacy and microenvironment changes of HER2 + gastric cancer during HLX02 and Endostar treatment using quantitative MRI.
Liang J; Dai W; Li Z; Liang X; Xiao M; Xie C; Li X
BMC Cancer; 2022 Oct; 22(1):1033. PubMed ID: 36192709
[TBL] [Abstract][Full Text] [Related]
5. Intravoxel incoherent motion diffusion-weighted imaging for monitoring chemotherapeutic efficacy in gastric cancer.
Song XL; Kang HK; Jeong GW; Ahn KY; Jeong YY; Kang YJ; Cho HJ; Moon CM
World J Gastroenterol; 2016 Jun; 22(24):5520-31. PubMed ID: 27350730
[TBL] [Abstract][Full Text] [Related]
6. Application of IVIM-DWI in Detecting the Tumor Vasculogenic Mimicry Under Antiangiogenesis Combined With Oxaliplatin Treatment.
Liang J; Li Z; Li J; Peng C; Dai W; He H; Zeng S; Xie C
Front Oncol; 2020; 10():1376. PubMed ID: 32974136
[No Abstract] [Full Text] [Related]
7. Dynamic Contrast Enhanced MRI and Intravoxel Incoherent Motion to Identify Molecular Subtypes of Breast Cancer with Different Vascular Normalization Gene Expression.
Tsai WC; Chang KM; Kao KJ
Korean J Radiol; 2021 Jul; 22(7):1021-1033. PubMed ID: 34047501
[TBL] [Abstract][Full Text] [Related]
8. Monitoring Vascular Disrupting Therapy in a Rabbit Liver Tumor Model: Relationship between Tumor Perfusion Parameters at IVIM Diffusion-weighted MR Imaging and Those at Dynamic Contrast-enhanced MR Imaging.
Joo I; Lee JM; Grimm R; Han JK; Choi BI
Radiology; 2016 Jan; 278(1):104-13. PubMed ID: 26200601
[TBL] [Abstract][Full Text] [Related]
9. Relationship between diffusion parameters derived from intravoxel incoherent motion MRI and perfusion measured by dynamic contrast-enhanced MRI of soft tissue tumors.
Marzi S; Stefanetti L; Sperati F; Anelli V
NMR Biomed; 2016 Jan; 29(1):6-14. PubMed ID: 26602061
[TBL] [Abstract][Full Text] [Related]
10. Intravoxel incoherent motion diffusion-weighted imaging of hepatocellular carcinoma: Is there a correlation with flow and perfusion metrics obtained with dynamic contrast-enhanced MRI?
Hectors SJ; Wagner M; Besa C; Bane O; Dyvorne HA; Fiel MI; Zhu H; Donovan M; Taouli B
J Magn Reson Imaging; 2016 Oct; 44(4):856-64. PubMed ID: 26919327
[TBL] [Abstract][Full Text] [Related]
11. Intravoxel Incoherent Motion MR Imaging in the Head and Neck: Correlation with Dynamic Contrast-Enhanced MR Imaging and Diffusion-Weighted Imaging.
Xu XQ; Choi YJ; Sung YS; Yoon RG; Jang SW; Park JE; Heo YJ; Baek JH; Lee JH
Korean J Radiol; 2016; 17(5):641-9. PubMed ID: 27587952
[TBL] [Abstract][Full Text] [Related]
12. intravoxel incoherent motion diffusion-weighted MRI assessing the effect of the vascular disrupting agent CA4P on VX2 liver tumors in rabbits.
Yang R; Wang Y; Duan Q; Qian T
Curr Med Imaging; 2023 Mar; ():. PubMed ID: 36876841
[TBL] [Abstract][Full Text] [Related]
13. Perfusion parameters of intravoxel incoherent motion based on tumor edge region of interest in cervical cancer: evaluation of differentiation and correlation with dynamic contrast-enhanced MRI.
Wang H; Zhu L; Li G; Zuo M; Ma X; Wang J
Acta Radiol; 2020 Aug; 61(8):1087-1095. PubMed ID: 31825761
[TBL] [Abstract][Full Text] [Related]
14. Intravoxel incoherent motion MRI for predicting early response to induction chemotherapy and chemoradiotherapy in patients with nasopharyngeal carcinoma.
Xiao-ping Y; Jing H; Fei-ping L; Yin H; Qiang L; Lanlan W; Wei W
J Magn Reson Imaging; 2016 May; 43(5):1179-90. PubMed ID: 26540374
[TBL] [Abstract][Full Text] [Related]
15. Intravoxel Incoherent Motion Diffusion Weighted MR Imaging for Monitoring the Instantly Therapeutic Efficacy of Radiofrequency Ablation in Rabbit VX2 Tumors without Evident Links between Conventional Perfusion Weighted Images.
Guo Z; Zhang Q; Li X; Jing Z
PLoS One; 2015; 10(5):e0127964. PubMed ID: 26020785
[TBL] [Abstract][Full Text] [Related]
16. Intravoxel incoherent motion diffusion-weighted MR imaging for monitoring the therapeutic efficacy of the vascular disrupting agent CKD-516 in rabbit VX2 liver tumors.
Joo I; Lee JM; Han JK; Choi BI
Radiology; 2014 Aug; 272(2):417-26. PubMed ID: 24697148
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance imaging-based approaches for detecting the efficacy of combining therapy following VEGFR-2 and PD-1 blockade in a colon cancer model.
Xu X; Ma M; Ye K; Zhang D; Chen X; Wu J; Mo X; Xiao Z; Shi C; Luo L
J Transl Med; 2024 Feb; 22(1):198. PubMed ID: 38395884
[TBL] [Abstract][Full Text] [Related]
18. Intravoxel incoherent motion diffusion-weighted MRI of invasive breast cancer: Correlation with prognostic factors and kinetic features acquired with computer-aided diagnosis.
Song SE; Cho KR; Seo BK; Woo OH; Park KH; Son YH; Grimm R
J Magn Reson Imaging; 2019 Jan; 49(1):118-130. PubMed ID: 30238533
[TBL] [Abstract][Full Text] [Related]
19. Intravoxel incoherent motion diffusion-weighted imaging in head and neck squamous cell carcinoma: assessment of perfusion-related parameters compared to dynamic contrast-enhanced MRI.
Fujima N; Yoshida D; Sakashita T; Homma A; Tsukahara A; Tha KK; Kudo K; Shirato H
Magn Reson Imaging; 2014 Dec; 32(10):1206-13. PubMed ID: 25131628
[TBL] [Abstract][Full Text] [Related]
20. MR imaging biomarkers evaluating vascular normalization window after anti-vessel treatment.
Yang J; Liao C; Liu Y; Yang G; Ke T; Ding Y; Li Q
Oncotarget; 2018 Feb; 9(15):11964-11976. PubMed ID: 29552285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
